125 related articles for article (PubMed ID: 38844365)
41. Chemotherapy-induced
Wang F; Zhao L; Zhang J; Meng Z; Zhou C; Wang G; Liu Y; Li M; Xi J; Niu W; Wang G
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30429233
[TBL] [Abstract][Full Text] [Related]
42. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
[TBL] [Abstract][Full Text] [Related]
43. Selective protection of human cardiomyocytes from anthracycline cardiotoxicity by small molecule inhibitors of MAP4K4.
Golforoush PA; Narasimhan P; Chaves-Guerrero PP; Lawrence E; Newton G; Yan R; Harding SE; Perrior T; Chapman KL; Schneider MD
Sci Rep; 2020 Jul; 10(1):12060. PubMed ID: 32694738
[TBL] [Abstract][Full Text] [Related]
44. Expression and prognostic significance of MAP4K4 in lung adenocarcinoma.
Qiu MH; Qian YM; Zhao XL; Wang SM; Feng XJ; Chen XF; Zhang SH
Pathol Res Pract; 2012 Sep; 208(9):541-8. PubMed ID: 22824148
[TBL] [Abstract][Full Text] [Related]
45. Silencing SOX2 Expression by RNA Interference Inhibits Proliferation, Invasion and Metastasis, and Induces Apoptosis through MAP4K4/JNK Signaling Pathway in Human Laryngeal Cancer TU212 Cells.
Yang N; Wang Y; Hui L; Li X; Jiang X
J Histochem Cytochem; 2015 Sep; 63(9):721-33. PubMed ID: 26001828
[TBL] [Abstract][Full Text] [Related]
46. Cellular MicroRNA Let-7a Suppresses KSHV Replication through Targeting MAP4K4 Signaling Pathways.
Tan X; Gao Y; Nan Y; Zhang J; Di C; Wang X; Lian F; Cao Y; Hu Y; Xu L; Ma H; Hong Y; Liu T; Wu Y; Xu X; Yan Y; Yang L
PLoS One; 2015; 10(7):e0132148. PubMed ID: 26197270
[TBL] [Abstract][Full Text] [Related]
47. A new function for MAP4K4 inhibitors during platelet aggregation and platelet-mediated clot retraction.
Nam GS; Kim S; Kwon YS; Kim MK; Nam KS
Biochem Pharmacol; 2021 Jun; 188():114519. PubMed ID: 33737052
[TBL] [Abstract][Full Text] [Related]
48. MAP4K4 Activation Mediates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis.
Wu C; Watts ME; Rubin LL
Cell Rep; 2019 Jan; 26(5):1143-1156.e5. PubMed ID: 30699345
[TBL] [Abstract][Full Text] [Related]
49. Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion.
Prolo LM; Li A; Owen SF; Parker JJ; Foshay K; Nitta RT; Morgens DW; Bolin S; Wilson CM; Vega L JCM; Luo EJ; Nwagbo G; Waziri A; Li G; Reimer RJ; Bassik MC; Grant GA
Sci Rep; 2019 Sep; 9(1):14020. PubMed ID: 31570734
[TBL] [Abstract][Full Text] [Related]
50. MAP4K4 negatively regulates CD8 T cell-mediated antitumor and antiviral immunity.
Esen E; Sergin I; Jesudason R; Himmels P; Webster JD; Zhang H; Xu M; Piskol R; McNamara E; Gould S; Capietto AH; Delamarre L; Walsh K; Ye W
Sci Immunol; 2020 Mar; 5(45):. PubMed ID: 32220977
[TBL] [Abstract][Full Text] [Related]
51. Bioinformatics and Experimental Analyses Reveal MAP4K4 as a Potential Marker for Gastric Cancer.
Zhang J; Cai X; Cui W; Wei Z
Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292671
[TBL] [Abstract][Full Text] [Related]
52. Microtubules regulate focal adhesion dynamics through MAP4K4.
Yue J; Xie M; Gou X; Lee P; Schneider MD; Wu X
Dev Cell; 2014 Dec; 31(5):572-85. PubMed ID: 25490267
[TBL] [Abstract][Full Text] [Related]
53. RBM4-SRSF3-MAP4K4 splicing cascade modulates the metastatic signature of colorectal cancer cell.
Lin JC; Lee YC; Tan TH; Liang YC; Chuang HC; Fann YC; Johnson KR; Lin YJ
Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):259-272. PubMed ID: 29138007
[TBL] [Abstract][Full Text] [Related]
54. Protein Kinase Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Promotes Obesity-induced Hyperinsulinemia.
Roth Flach RJ; Danai LV; DiStefano MT; Kelly M; Menendez LG; Jurczyk A; Sharma RB; Jung DY; Kim JH; Kim JK; Bortell R; Alonso LC; Czech MP
J Biol Chem; 2016 Jul; 291(31):16221-30. PubMed ID: 27226575
[TBL] [Abstract][Full Text] [Related]
55. Map4k4 is up-regulated and modulates granulosa cell injury and oxidative stress in polycystic ovary syndrome via activating JNK/c-JUN pathway: An experimental study.
Ding L; Jiang L; Xing Z; Dai H; Wei J
Int Immunopharmacol; 2023 Nov; 124(Pt A):110841. PubMed ID: 37647682
[TBL] [Abstract][Full Text] [Related]
56. Molecular characterization of Ste20p, a potential mitogen-activated protein or extracellular signal-regulated kinase kinase (MEK) kinase kinase from Saccharomyces cerevisiae.
Wu C; Whiteway M; Thomas DY; Leberer E
J Biol Chem; 1995 Jul; 270(27):15984-92. PubMed ID: 7608157
[TBL] [Abstract][Full Text] [Related]
57. Vascular smooth muscle RhoA counteracts abdominal aortic aneurysm formation by modulating MAP4K4 activity.
Molla MR; Shimizu A; Komeno M; Rahman NIA; Soh JEC; Nguyen LKC; Khan MR; Tesega WW; Chen S; Pang X; Tanaka-Okamoto M; Takashima N; Sato A; Suzuki T; Ogita H
Commun Biol; 2022 Oct; 5(1):1071. PubMed ID: 36207400
[TBL] [Abstract][Full Text] [Related]
58. Silencing mitogen-activated protein 4 kinase 4 (MAP4K4) protects beta cells from tumor necrosis factor-alpha-induced decrease of IRS-2 and inhibition of glucose-stimulated insulin secretion.
Bouzakri K; Ribaux P; Halban PA
J Biol Chem; 2009 Oct; 284(41):27892-27898. PubMed ID: 19690174
[TBL] [Abstract][Full Text] [Related]
59. MAP4K4/JNK Signaling Pathway Stimulates Proliferation and Suppresses Apoptosis of Human Spermatogonial Stem Cells and Lower Level of MAP4K4 Is Associated with Male Infertility.
Wan C; Chen W; Cui Y; He Z
Cells; 2022 Nov; 11(23):. PubMed ID: 36497065
[TBL] [Abstract][Full Text] [Related]
60. In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer.
Chang CD; Chao MW; Lee HY; Liu YT; Tu HJ; Lien ST; Lin TE; Sung TY; Yen SC; Huang SH; Hsu KC; Pan SL
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2166039. PubMed ID: 36683274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
